The underlying protective mechanism was found to be associated with the regulation of necroptosis mediated by the RIP1/RIP3/MLKL signaling pathway, which suggested that PA/CCMTS-P enemas could serve as a promising therapeutic strategy for ulcerative colitis. This evidence concerns the gene MLKL and ulcerative colitis.